Industry

DUBLIN–(BUSINESS WIRE)–The “Cellulitis – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. This “Cellulitis- Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Cellulitis, historical and forecasted epidemiology as well as the Cellulitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and … [Read more…]

With rising rates of colorectal cancer in adults under 50, this research is a first step to noninvasively and inexpensively detect colorectal cancer at an earlier and more treatable stage. LOS ANGELES–(BUSINESS WIRE)–Scientists at City of Hope, one of the largest cancer research and treatment organizations in the United States, may have developed a novel … [Read more…]

– Use of LNP Simplifies Administration of LinearDNA-based Therapies, Potentially Enabling Their Application in Large Scale – STONY BROOK, N.Y.–(BUSINESS WIRE)–$APDN #LNP—Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced that LineaRx, the Company’s majority-owned biotherapeutics subsidiary, has for the first time successfully administered and expressed a linearDNA-LNP … [Read more…]

Partnership enhances educational pathways to medicine and provides up to $10,000 in additional student funding CHICAGO–(BUSINESS WIRE)–$ATGE #WeAreAdtalem–Adtalem Global Education (NYSE: ATGE), a leading educator and provider of professional talent to the healthcare industry, has established a partnership between its two medical schools, American University of the Caribbean School of Medicine (AUC) and Ross University … [Read more…]

ATLANTA–(BUSINESS WIRE)–PrimeRevenue, the global leader in working capital and B2B payment solutions, today published its new eBook, How Supply Chain Financing Brings the Healthcare Supply Chain to Scale. Written for pharmaceutical and medical product manufacturers, the guide provides an analysis of the challenges currently facing healthcare suppliers—and outlines the ways in which supply chain finance … [Read more…]

– Assembly of recognized experts to bring complementary experience and insights to Rockley’s ongoing efforts to revolutionize wearable biosensing technology OXFORD, England & PASADENA, Calif.–(BUSINESS WIRE)–Rockley Photonics Holdings Limited (NYSE: RKLY) (“Rockley”), a global leader in photonics-based health monitoring and communications solutions, today announced the formation of a scientific advisory board (SAB) gathering world-renowned experts … [Read more…]

Funding is part of UnitedHealthcare’s $11 million in Empowering Health grants focused on expanding access to care and addressing the social determinants of health for people in underserved communities DETROIT–(BUSINESS WIRE)–UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, is awarding $1 million in Empowering Health grants to five community-based organizations in Michigan to expand access to … [Read more…]

Funding is part of UnitedHealthcare’s $11 million in Empowering Health grants focused on expanding access to care and addressing the social determinants of health for people in underserved communities OKLAHOMA CITY–(BUSINESS WIRE)–UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, is awarding $500,000 in Empowering Health grants to three community-based organizations in Oklahoma to expand access to … [Read more…]

SAN FRANCISCO–(BUSINESS WIRE)–$TIVC #healthcare—Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that it will report financial results for the second quarter of 2022 via conference call and webcast, Monday, August 15, 2022, at 1:30 pm PT / 4:30 pm ET. Teleconference Details: Toll-Free: 877-545-0320 … [Read more…]

PHILADELPHIA–(BUSINESS WIRE)–Aro Biotherapeutics, a biotechnology company pioneering the development of tissue-targeted genetic medicines, today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for ABX1100, an investigational Centyrin-siRNA conjugate that targets the Gys1 gene in the muscle, for the treatment of Pompe disease. “We are pleased to have received this designation … [Read more…]